Connect with us

Cancer

#EuropaColon 2nd Masterclass

SHARE:

Published

9 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

In partnership with the ESMO World Congress on Gastrointestinal Cancer in Barcelona, EuropaColon will bring together senior representatives from their Affiliate and Associates Groups for the 2nd Advocacy Masterclass.

The meeting is designed to offer information, support and advice to the Advocates bringing together senior clinical and advocacy figures from the world of cancer in Europe and the US. Attendees will hear the latest news on treatment options for colorectal, pancreatic and gastric cancer patients; discuss ways to better support patients with these cancers; share best practices and spend time networking with colleagues and fellow advocates.

Hosted within the CCIB Congress Centre from 29 June – 1 July, the meeting offers a dynamic opportunity for the Advocates to share their challenges, and identify ways to improve their support for patients.

More information about the agenda is available on the EuropaColon website. 

EuropaColon is a European-wide platform for colorectal cancer (CRC) aiming to raise awareness, support patients, and campaign for equity of access to best treatment and care. 2017 plans include working with the Commission on standards of care for CRC patient pathways; re-energizing screening efforts with a dedicated Task Force, composed of countries with excellent screening rates; undertaking a Europe-wide survey of the Unmet Needs of Patients with CRC. Work will also continue with our member groups to support their local policy and national initiatives. Currently, with 43 member groups in 32 countries, only a few remain outside the fold. In the future, EuropaColon will expand its remit to other digestive cancers. Follow us on Twitter & Facebook.

 

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending